Simultaneous screening for head and neck, lung cancers may improve early detection, survival
the ONA take:
According to a new analysis published in the journal Cancer, researchers from the University of Pittsburgh Cancer Institute in Pittsburgh, Pennsylvania, have found that screening patients for head and neck cancer and lung cancer could improve early detection and survival.
The multidisciplinary team analyzed data from 3,587 patients from the Pittsburgh Lung Screening Study (PLuSS) to investigate whether those patients, which included both current and ex-smokers, had a higher risk of developing head and neck cancer.
Results showed that the rate of head and neck cancer among the PLuSS participants was 71.4 cases annually per 100,000 people compared with the expected 43 cases annually per 100,000 in the general U.S. population.
Because head and neck cancer is rare in comparison to the most common cancer types, the researchers note that it would be impractical to screen the general population for the disease, but patients at risk for lung cancer that would be referred for lung cancer screening would most likely benefit from head and neck cancer screenings as well.
The researchers are now designing a national study to assess the effect of simultaneous lung and head and neck cancer screening on mortality.
Screening patients for head and neck cancer and lung cancer could improve early detection and survival.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|